Your session is about to expire
← Back to Search
Virtual Care for Heart Failure
N/A
Recruiting
Led By Harriette Van Spall, MD
Research Sponsored by Population Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
Study Summary
This trial will study if virtual healthcare can improve care for Canadians with heart failure and make it more accessible.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in heath status
Secondary outcome measures
Number of patients randomized
Number of visits per patient during 90 days
Proportion of patients allocated to the virtual HF clinic who require crossover to the routine HF clinic
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Virtual HF careExperimental Treatment1 Intervention
Patients will receive virtual HF care to optimize medical therapies
Group II: Routine HF careExperimental Treatment1 Intervention
Participants will receive routine HF care
Find a Location
Who is running the clinical trial?
Population Health Research InstituteLead Sponsor
155 Previous Clinical Trials
679,862 Total Patients Enrolled
9 Trials studying Heart Failure
33,499 Patients Enrolled for Heart Failure
Hamilton Health Sciences CorporationOTHER
368 Previous Clinical Trials
300,943 Total Patients Enrolled
10 Trials studying Heart Failure
34,257 Patients Enrolled for Heart Failure
McMaster UniversityOTHER
881 Previous Clinical Trials
2,597,840 Total Patients Enrolled
9 Trials studying Heart Failure
910,259 Patients Enrolled for Heart Failure
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your NT-proBNP level is higher than 900 pg/ml.Adults over 18 years old who were recently in the hospital for heart failure or had an urgent visit for heart failure, or have an appointment with a heart doctor within 30 days of being in the hospital or having an urgent visit for heart failure.Your heart's pumping ability, measured as LVEF, is less than 55% in the last 3 months.
Research Study Groups:
This trial has the following groups:- Group 1: Routine HF care
- Group 2: Virtual HF care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this trial still open?
"Affirmative. Clinicaltrials.gov lists this clinical trial as actively recruiting and states that it was first made available on December 9th 2022. The study is looking for 50 participants from 3 distinct healthcare facilities, with the last update occurring on February 1st 2023."
Answered by AI
What is the maximum participant capacity of this clinical trial?
"Indeed. The clinical trial data posted on clinicaltrials.gov states that the study is currently recruiting participants, having been first published on December 9th 2022 and most recently updated on February 1st 2023. Approximately 50 patients are being sought from 3 distinct medical facilities."
Answered by AI
Recent research and studies
Popular Categories
Share this study with friends
Copy Link
Messenger